Genetic Analysis Market (By Product: Reagents & Kits, Instruments, Software; By Test: Predictive Genetic Testing, Carrier Testing, Prenatal and Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Others; By Technology: Next-Generation Sequencing, Real-Time PCR System, Others; By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Genetic Analysis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Genetic Analysis Market, by Product, 2024-2033
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2021-2033)
9.1. Genetic Analysis Market, by Test, 2024-2033
9.1.1. Predictive Genetic Testing
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Carrier Testing
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Prenatal and Newborn Testing
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Disease Diagnostic Testing
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Pharmacogenomic Testing
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
10.1. Genetic Analysis Market, by Technology, 2024-2033
10.1.1. Next-Generation Sequencing (NGS)
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Real-Time PCR System
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2033)
11.1. Genetic Analysis Market, by Application, 2024-2033
11.1.1. Cancer
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Genetic Diseases
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cardiovascular Diseases
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Rare Diseases
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Infectious Diseases
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2021-2033)
12.1. Genetic Analysis Market, by End-use, 2024-2033
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Research & Development Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Diagnostic Centers
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2021-2033)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.7. Market Revenue and Forecast, by Application (2021-2033)
13.2.8. Market Revenue and Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.10. Market Revenue and Forecast, by Application (2021-2033)
13.2.11. Market Revenue and Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.13. Market Revenue and Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.15. Market Revenue and Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.7. Market Revenue and Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.9. Market Revenue and Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.7. Market Revenue and Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.9. Market Revenue and Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.7. Market Revenue and Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)
14.1. Thermo Fisher Scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. PerkinElmer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. BioRad Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AutoGenomics Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ELITech Group
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. IntegraGen
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Quest Diagnostics Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Hoffmann-La Roche AG
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Celera Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client